Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

Publisher： Karger

E-ISSN： 1660-2862|16|1-2|69-76

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.16, Iss.1-2, 2016-0, pp. : 69-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 4, 2010-05 ,pp. : 251-259

Karger

Access to resources Recommend Favorite

Effectiveness of Nonpharmacological Approaches in Patients with Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 8, Iss. 3, 2010-12 ,pp. : 138-145

Karger

Access to resources Recommend Favorite

Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 4, Iss. 6, 2007-10 ,pp. : 406-412

Karger

Access to resources Recommend Favorite

Combination of Biomarkers: PET [18F]Flutemetamol Imaging and Structural MRI in Dementia and Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-02 ,pp. : 246-249

Karger

Access to resources Recommend Favorite

Hippocampal Drebrin Loss in Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-02 ,pp. : 216-219

Karger

Access to resources Recommend Favorite